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Abstract. Ascorbic acid in soluble extracts of neural 
tissue can account for the increase in surface acetyl- 
choline receptors (AChR's) seen on L5 myogenic cells 
treated with crude brain extract (Knaack, D., and T. 
R. Podleski,  1985, Proc. Natl. Acad. Sci.  USA., 
82:575-579).  The present study further elucidates the 
nature of the response of L5 cells to ascorbic acid. 
Light autoradiography showed that ascorbic acid treat- 
ment affects both the number and distribution of sur- 
face AChR's. Ascorbic acid, like crude brain extracts, 
caused a three- to fourfold increase in average AChR 
site density. However, the number of AChR clusters 
induced by ascorbic acid was only one-fifth that ob- 
served with crude brain extract. 
The rate constant for degradation of AChR in ascor- 
bic acid-treated cells of 0.037 __. 0.006 h -1 (t,/2 =  19 h) 
was not significantly different from that in untreated 
controls of 0.050 ___ 0.001  h -1 (t,/2 =  14 h). The in- 
crease in AChR site density is primarily due to a 2.8- 
fold increase in the average rate of AChR incorpora- 
tion. Ascorbic acid also stimulates thymidine incorpo- 
ration and increases the total number of nuclei per 
culture. However, cellular proliferation is not respon- 
sible for the increase in AChR's since 10 #M cytosine 
arabinofuranoside blocks the mitogenic effect without 
affecting the AChR increase. The specificity of ascor- 
bic acid on AChR expression was established by show- 
ing that (a) ascorbic acid produced only a slight in- 
crease in total protein, which can be accounted for by 
the mitogenic effect, and (b) the normal increase seen 
in creatine kinase activity during muscle differentia- 
tion was not altered by the addition of ascorbic acid. 
We conclude that the action of ascorbic acid on 
AChR number cannot be explained by changes in cell 
growth, survival, differentiation, or protein synthesis. 
Therefore, in addition to a minor stimulation of 
AChR clustering, ascorbic acid specifically affects 
some aspect of the AChR biosynthetic pathway. 
W 
HEN spinal cord explants are co-cultured with my- 
ogenic cells, the expression  of acetylcholine recep- 
tors (AChR's)'  on myotubes is affected primarily 
in two ways. The overall receptor site density is increased and 
discrete  receptor clusters  are formed (9, 34). Several studies 
have  suggested  that  the  spinal  cord  explants  could  affect 
AChR  number and distribution via the  release  of soluble 
factors (2, 7, 17, 34, 4 l). 
Studies  using partially purified brain  and  nerve-derived 
substances indicate that  more  than  one  factor may affect 
AChR expression.  Formation of receptor clusters  has been 
observed in a number of systems and has been associated with 
components having a range of molecular weights (2,  17, 28, 
34). But according to Neugebauer et al. (3 l), clustering activity 
is greatest in the high molecular weight range. On the other 
hand, significant increases  in the overall  AChR site density 
have only been demonstrated on primary chick skeletal mus- 
cle (17) and the L5 and L6 cloned cell lines (21, 23, 31, 34), 
and are produced by substance(s)  with apparent molecular 
weight(s) of < 1,500 (5,  17, 21, 23, 31). Knaack and Podleski 
Abbreviations used in this paper.- AChR, acetylcholine receptor;  Ara-C, cyto- 
sine arabinofuranoside; a-BGT, a-bungarotoxin; DME, Dulbecco's modified 
Eagle's medium; [aH]Thy, tritiated thymidine. 
(23) have recently identified  ascorbic acid as the low molecular 
weight component from fetal calf brain responsible  for in- 
creasing the number of AChR's on the myogenic cell line Ls. 
The present studies were undertaken to further elaborate 
the effect of ascorbic  acid treatment on AChR site density 
and clustering, and to determine whether ascorbic acid treat- 
ment can fully account for the effects of  brain extract on these 
parameters. We find that the increase  in AChR site density 
observed with brain extract can be accounted for by ascorbic 
acid. This increase is due primarily to an increase in the rate 
of AChR insertion into surface  membrane rather than to a 
decrease  in  the  rate  of degradation.  Furthermore,  general 
effects of ascorbic acid on protein levels, cell survival, or the 
fusion of myoblasts cannot account for the AChR increase 
produced by  ascorbic  acid.  The  main  difference between 
ascorbic acid and brain extract is the ability of brain extract 
to induce a greater number and density of AChR clusters. 
Materials and Methods 
Cell Culture 
L~ cells were cultured as reported previously (23). Briefly, cells were plated in 
Dulbecco's modified Eagle's medium (DME) plus 10% heat-inactivated fetal 
calf serum, at a density of 5 x  104 cells/ml, into individual wells (0.5 ml/well) 
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indicated otherwise,  15 gl of a  freshly prepared  1 mg/ml ascorbic acid (ICN 
K&K Laboratories Inc., Plainview, NY) stock, prepared in H20 and sterilized 
through a 0.45-#m filter (Gelman Sciences, Inc., Ann Arbor, MI), was added 
to triplicate wells, one dose per day, for two consecutive days beginning either 
the fourth or fifth day after plating. This dose yields a  tnaximal increase in 
AChR's (see Fig. 2). 
Total Culture-AChR Assay 
~2Sl-,-Bungarotoxin (1251-BGT) binding was used to measure AChR levels. In 
this study, AChR site density refers to the aeetylcholine or BGT binding site 
density, since specific BGT binding has been shown to correlate with acetyl- 
choline sensitivity in rat myotubes (25).  ~2~I-BGT was prepared in our labora- 
tory (26) and used to assay whole culture AChR levels as reported previously 
(23). The total counts of 1251-BGT bound for a given treatment were calculated 
as the mean for triplicate determinations per culture. Nonspecific binding was 
determined for each multiwell plate by preincubating triplicate wells with 100 
nM  unlabeled BGT  for  15  min prior to labeling with ~2SI-BGT. The  mean 
counts bound per well were taken as the level of nonspecific binding. Specific 
binding was determined by subtracting the mean nonspecific binding for the 
respective  dish from the mean total binding for a given determination. Standard 
errors of the mean (SEMs) for specific BGT binding were calculated from the 
square root of the sums of squares of the standard errors for the nonspecific 
and total binding. 
Autoradiography 
L~ cells in 35-mm dishes were labeled for 30 min using 20 nM  ~25I-BGT in 
Tyrodes buffer with 2  mg/ml bovine serum albumin. The labeled BGT was 
aspirated offand the cells were washed in Tyrodes-BSA for a minimum of five 
rinses of 5 ml each over the course of 30 min. The cultures were then fixed for 
30  min  in  2%  glutaraldehyde in 0.1  M  sodium  phosphate buffer (dibasic). 
Glutaraldehyde was removed with three rinses in 0.1  M sodium phosphate plus 
0.2 M sucrose. Distilled water was used for the final rinse. After air drying, the 
cells were prepared for autoradiography by the stripping film method described 
by  Land  et  al. (25)  (for greater detail see reference  35).  In  this method,  a 
preformed monolayer of llford L4 emulsion, dried on a collodion-coated slide, 
is stripped and applied to the cultures. (The sensitivity of the emulsion had 
been previously assessed using a known source of iodine 125 [12].) Different 
exposure times were used for various autoradiograms. In one, the emulsions 
were overexposed to facilitate identification and counting of receptor clusters. 
In the other, exposure times were chosen to allow the counting of individual 
developed grains in  regions of the  muscle not containing very high density 
receptor clusters. These exposure times were calculated to give grain densities 
in the linear part of the dose response curves for llford L4 emulsion developed 
with Kodak DI9 (i.e., 0.03 to 0.5 grains/#m  2) (37). 
Scanning Electron Microscopy and Autoradiography 
Scanning electron microscopy and autoradiography were performed according 
to the methods outlined by Neugebauer et at. (31). 
AChR Site Density Assessed by Grain Counting 
Grain counting was performed as described by Neugebauer et al. (31).  A grid 
in the microscope ocular (total area =  7,600 um2; subdivision of 39 ~m  2 each) 
was used for grain counting. Myotubes were selected by placing the microscope 
objective (1,000x,  oil immersion) over a  randomly chosen area of the dish. 
The stage was then moved until the first myotube appropriate for counting was 
intersected with the upper left-hand corner of the gradicule. To be considered 
appropriate for counting, a myotube area of at least 2,500 ~m  2 in size had to 
be free of overlying debris and mononucleated cells. Any myotube appearing 
phase bright or damaged was not counted. Average AChR site densities for a 
2,500 ~m  2 area in a minimum of eight myotubes from each of duplicate dishes 
were calculated using the equation given in Matthews-Bellinger and Salpeter 
(29). 
Assessment of  Receptor Clustering 
(a) The number of clusters per square micrometer of myotube was determined 
from overexposed autoradiograms. Clusters were subjectively  defined as discrete 
regions  of  intense  grain  density  identified  with  bright  field  optics at  low 
magnification. A grid in the ocular (total area =  119 x  10  a ~m2; subdivision of 
600 um  2) was used to define the dimensions of a  field. Clusters substantially 
less in area than one-fourth of a grid subdivision (i.e., <<  150 tzm  2) were not 
scored. The myotube surface area present in a particular field was determined 
under phase-contrast optics by determining the fraction of grid intersections 
that fell over myotubes (see reference 31 ). The number of clusters and myotube 
surface area were determined for each of 15 fields on duplicate dishes for each 
treatment. 
(b) High density receptor clusters were studied using dishes exposed for grain 
counting (see above). Clusters were located by systematically scanning sequen- 
tial fields on a  given dish with bright field optics (1000x, oil immersion). A 
field was defined by the grid in the ocular (7,600 um2). Clusters were identified 
subjectively (as outlined above), and only those greater than one grid subdivi- 
sion (39 um  2) in area were scored.  Once a  cluster was identified, the grain 
density for the entire cluster was determined as outlined for grain counting. 
The  boundaries of a  cluster were  defined subsequently as  only those grid 
subdivisions containing a grain density of greater than three times the average 
intercluster site density previously determined for the entire dish (see ref.  31 
for calculation of intercluster site density). 
Site densities of 2,000 sites per square micrometer in these experiments are 
comparable to the high density clusters of Neugebauer et al. (31 ) with ratios of 
cluster to intercluster site densities of greater than 9. 
3  H-  Thymidine ([3  H]  Thy) Incorporation 
[3H]Thy incorporation was studied by a  modification of the method of Gos- 
podarowicz et al. (13).  Each determination was made in triplicate.  10 ul of 
DME containing 1 t~Ci  of [3H]Thy and 5 ng of unlabeled thymidine were added 
to  each  well of L5  cells in  multiwell tissue culture dishes.  After 4-6  h  of 
incubation at 37"C the medium was aspirated, and the wells were rinsed twice 
with 1 ml of DME.  Phosphate-buffered saline (PBS)  (100 #1) was then added 
to  each  well and  each  well  was  swabbed  with a  5-cm-long cotton  tipped 
applicator. Microscopic examination of the wells demonstrated that no cells 
remained.  The  wooden  ends  of the  applicators were  then  inserted  into  a 
styrofoam holder, which was inverted so that the tips of the applicators were 
immersed into a glass bath containing 250 ml of cold 10% trichloroacetic acid. 
A magnetic stir bar provided gentle stirring. After 20 rain, the applicators were 
removed and washed in the same way for  10 rain in cold 5% trichloroacetic 
acid.  A  third  wash  was performed  in  cold  95%  ethanol  for  15  min.  The 
applicators were then dried in a 37"C oven. The cotton tips were cut and placed 
into 10 ml of Aquasol (New England Nuclear, Boston, MA) filled scintillation 
vials, and counted in a Beckman LS-230 scintillation counter. 
Nuclei in Myotubes 
Ascorbic acid-treated cultures received 15 ug/d of ascorbic acid according to 
the  protocol  used  for AChR determination. The  distribution of nuclei was 
determined on day 7 as reported previously (21).  In summary, cells were fixed 
in 95% ethanol for 5 min. The ethanol was then removed and the dishes were 
allowed to  air  dry  prior  to  staining for  8  h  with  hematoxylin.  After  the 
hematoxylin stain had been removed, the dish was rinsed several times with 
ethanol and tap water. 
The number of nuclei per myotube was determined under phase-contrast at 
240x.  For a  given treatment, all the nuclei in  myotubes for five randomly 
chosen fields of 53  x  10  a #m  2 each, were counted in each of two duplicate 
cultures.  The  nuclei in  nonfused  cells were also counted.  The  means  and 
standard errors for l0 fields in each of triplicate cultures were determined. 
Creatine Kinase Determination 
Cultures were grown in multiwell plates as outlined above. Duplicate sets of 
triplicate (day 6 and 7) or quadruplicate (days 3, 4, and 5) wells were dosed 
with  ascorbic  acid  according to  the  AChR  assay  protocol.  Cultures  were 
harvested on the specified days by washing each well twice with cold PBS (pH 
7.4).  The  cells from  replicate cultures  were  then  harvested with  a  rubber 
policeman and pooled. The empty wells were rinsed with 100 #1 lysis buffer 
(50 mM glycylglycine-HCl,  pH 6.7, 0. 1% 2-mercaptoethanol, and 1% Nonidet 
P-40, and 0.9 ml PBS).  The PBS washes for each culture were added to the 
harvested cells, sonicated for 15 s at 4°C, and stored in liquid nitrogen. Creatine 
kinase activity was determined by the spectrophotometric coupled assay of 
Nielson and Ludvigsen (32).  Creatine kinase determination reagents (#45-UV) 
and  purified  rabbit  creatine  kinase  standard  were  purchased  from  Sigma 
Chemical Co., St. Louis, MO. 
AChR Degradation 
Degradation of surface membrane AChR's was determined according to the 
method  of Devreotes and  Fambrough  (10).  Growth  media was  aseptically 
removed from all the cultures at the start of an experiment and saved at 38"C. 
The  medium  was  replaced  with  Tyrodes-BSA  solution,  and  cultures  were 
labeled with ~25I-BGT as described above. The Tyrodes solution from the final 
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to  the  cultures,  and  the  labeled  cultures  were  returned  to  the  incubator. 
Nonspecific binding  was determined  by pre-treating  cultures  with unlabeled 
BGT as outlined  above for AChR assay. The amount of BGT bound to the 
cells was determined  at various times over the next 40 h. At each time point, 
the media was aspirated and each well was rinsed twice with fresh DME without 
serum supplement.  Triplicate determinations  of total and nonspecific binding 
remaining  on the tissue culture cells were made for each time point. Cultures 
were digested overnight in 2.0 N NaOH and harvested as described above. 
Protein Assay 
The protein content in the cell sonicates prepared for creatine kinase assay was 
determined  by the method of Lowry et ai. (27), using bovine serum albumin 
as a  standard.  The cell sonicates  were diluted  ten  times  with  water  before 
adding to the reaction mixture. 
Fetal Brain Extracts 
0.2  M ammonium acetate  fetal calf brain  extract  was prepared  as described 
previously  (23). Newborn  rat  brain  extract  was prepared  as  described  by 
Podleski et al.  (34) except  using PBS, pH 7.4. Data  for crude  extract  were 
obtained using the same dosage regime as for ascorbic acid. Extracts were added 
at doses yielding maximum AChR increases (21, 34). 
Results 
Ascorbic Acid Increases Total Culture AChR and 
Surface Membrane AChR Site Density 
Measurements  of total  culture  AChR levels  (using gamma 
counting)  in  untreated  cultures  showed  that  BGT  binding 
increased from 0.98 __. 0.50 fM (mean __. SEM; n =  3) on day 
4 in culture to 6.33 _  0.70 fM on day 7. This increase is most 
likely due to an  increase  in the  total  number of myotubes 
since fusion is occurring rapidly during this period. If ascor- 
bate was added to matched cultures on days 4 and 5, the total 
BGT  bound  on  day  7  was  increased  to  20.7  ___  1.2  fM, 
representing  a  3.2-fold  increase  over  that  in  controls.  To 
determine  the effect on AChR site density per unit area of 
myotube, autoradiography and grain counting were used. Ls 
myotubes are very branched (see Fig.  1), and it is impossible 
to  count grains  over an  entire  tube.  Average site  densities 
were obtained for at least 2,500 um  2 per myotube as described 
in  Materials  and  Methods.  Autoradiography  showed  that 
ascorbic acid treatment causes a  3.6-fold increase in AChR 
site density per square micrometer of myotube surface (Table 
I). This increase was of the same magnitude as the increase 
in  AChR per total  culture  observed with  gamma counting 
techniques and is not significantly different from that occur- 
ring after treatment with crude fetal calf or rat brain extract. 
Control levels of AChR site density on day 7 for three exper- 
iments were 73.6 _  11 (mean _+ SEM) ~2SI-BGT  binding sites 
per square  micrometer.  The  mean  site  density  on  cultures 
treated with 30 ug/ml ofaseorbic acid was 270 ___ 32 125I-BGT 
binding sites/um 2. These data indicate that the AChR increase 
observed in response to ascorbic acid is not due to a survival- 
or differentiation-promoting effect of ascorbic acid,  leading 
to  a  greater  number  of differentiated  myotubes,  each  with 
normal AChR levels.  Rather,  the increase in AChR's is due 
to an increased level of  surface AChR expression in individual 
differentiated myotubes. 
Figure 1.  Scanning electron microscope autoradiogram of L5 cell.  This micrograph illustrates the highly branched nature of the myotubes (M) 
from these cells.  Arrowheads help delineate  the cell  outline.  Developed grains are seen as fine white specks generally uniformly distributed 
throughout myotube, but not present on mononucleated cells (m). Bar,  100 ~m. 
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Cellular Effects 
Crude brain* ex-  Ascorbic acid/ 
tract/control  control* 
Parameter measured  (+ SEM)  (_+SEM) 
Total protein s  1.39 _ 0.04 (5)  1.25 + 0.04 (4) 
CK activity/well  1.10 _ 0. I0 (5)  1.18 _ 0.10 (4) 
[3H]Thy incorporation  3.10 _+ 0.50 (4)  2.66 -+ 0.45 (4) 
(day 6) 
AChR total culture m  4.10 _ 0.80 (5)  3.50 + 0.45 (5) 
AChR site density  ~  2.83 _+ 0.45 (2)  3.67 ___ 0.48 (3) 
The values given are  the  mean values for extract-  or ascorbic acid-treated 
cultures, divided  by the  value for untreated  controls.  The values given were 
determined  on day 7, using the standard  dosage regime, except for thymidine 
incorporation  which was determined  on day 6.  The number in parentheses 
refers to the number of experiments done. 
* Fetal  calf brain  extract  was used  for all determinations  except AChR  site 
density, in which newborn rat brain extract was used. 
*  See Fig. 3 and Results for actual experimental values. 
The level of total protein  in ascorbic acid-treated  cultures was significantly 
different  (P  <  0.05) from  the  level in  extract-treated  cultures.  No  other 
determinations  were significantly different between extract- and ascorbic acid- 
treated cultures. 
I By gamma counting. 
By light microscope autoradiography. 
AChR Accumulation Is Independent of 
Myoblast Proliferation 
The addition of ascorbic acid induces myoblast proliferation 
in L5 cultures. This was established by determining the level 
of [3H]Thy incorporated into chromosomal DNA during 4-h 
pulse periods as outlined in Materials and Methods. 24 h after 
the first dose of ascorbic acid, the amount of [3H]Thy incor- 
porated over the 4-h pulse period was 2.0 +  0.28  (mean  ___ 
SEM,  n  =  4)  times  the  amount  of untreated  controls.  If 
[3H]Thy was added  at 48  h  after the first  dose of ascorbic 
acid, incorporation over the 4-h pulse period was 2.66 _+ 0.45 
(mean +  SEM, n = 4) times control, and if added at 72 h (the 
time of the AChR assay), [3H]Thy incorporation was approx- 
imately equal to controls. 
Since increased [3H]Thy incorporation over the first 48 h 
indicated that  there was an induction  of myoblast division 
following the addition of ascorbic acid, there was a possibility 
that ascorbic acid caused some change in the newly divided 
mononucleated cells,  which lead to increased AChR expres- 
sion.  Two experimental  results  indicate  that  the  mitogenic 
effect is not responsible for mediating the effects of ascorbic 
acid  on  AChR  levels.  (a)  Although  the  total  number  of 
mononucleated cells formed in the presence of ascorbic acid 
is 2.30 _  1.34 (mean +  SEM, n  --- 3) times control, most of 
these myoblasts had not fused by the time the AChR deter- 
mination was made. On day 7 the number of nuclei present 
in myotubes ofascorbic acid-treated cultures was 1.38 + 0.29 
times control. (b) The mitogenic effect of ascorbic acid can 
be blocked by the addition of 10 t~M cytosine arabinofuran- 
oside (Ara-C) without altering the effect of ascorbic acid on 
the level of AChR's. In four paired experiments,  the maxi- 
mum response to ascorbic acid in Ara-C-treated cultures was 
3.6  ___  0.63  (mean  ___  SEM)  times  control  which  was  not 
significantly different from the maximum response of 3.8 + 
0.18 (mean _  SEM) times control obtained from cultures in 
the  absence of Ara-C.  Representative  dose  response  curves 
with  and  without  Ara-C are  shown  in  Fig.  2.  Under these 
conditions, Ara-C reduced thymidine incorporation over the 
pulse period by greater than 90%, from 16,933 _  972 to 616 
___ 265 clam (mean ___ range; n -- 2) in ascorbate-treated cultures 
and  from  6,396  _  1,022  to  593  _  243  cpm  in  untreated 
controls. 
AChR Induction Is Due to an Increased Rate of  AChR 
Insertion into the Surface Membrane 
Autoradiography and the total culture AChR assay by gamma 
counting are static measures of the number of AChR on the 
myotube  membrane  surface.  The  ascorbic  acid-induced 
AChR increase could be due to either an increased rate of 
insertion of receptors into the muscle membrane surface, or 
to a slowing of the degradation rate of surface AChR's. The 
rates of  receptor degradation and accumulation were therefore 
measured in ascorbate-treated and control cultures.  A  slight 
decrease in degradation rate was found after ascorbate treat- 
ment, from a mean rate constant of 0.050 _+ 0.001 h -j (mean 
_+ SEM; n =  5) (t,/z =  13.9 h) inuntreated controls, to one of 
0.037 _+ 0.006 h -~ (t,,~ =  18.7 h) for ascorbate-treated cultures. 
Although these  means are not significantly different at P  = 
0.1 (Students' t test with Cochrans' distribution for nonhomo- 
geneous variance [8]), the variances are (P <  0.05) (8). These 
data suggest a small, but not consistent, effect of ascorbate on 
receptor degradation rate under our experimental conditions. 
Both  the  means  and  the  change  in  variance  are  in  close 
agreement with the values that were reported by Neugebauer 
et al. (31) for L5 cells with and without brain extract treatment. 
Given the observed rates of receptor degradation, the extent 
to which the increased receptor site density must be due to 
an increase in the rate  of receptor insertion  was calculated 
using the equation of Schimke and Doyle (38): 
dA/dt = k+(t) -  k_A(t), 
where,  at  a  given time  (t),  dA/dt is the average net AChR 
accumulation rate, A equals the concentration of AChR, k÷ 
is the AChR incorporation rate and k_ is the degradation rate 
for AChR. Fig. 3A illustrates that AChR levels in untreated 
control dishes increased continuously over the experimental 
period.  This increase  may be due to the  formation of new 
myotubes during the experiment or to an ongoing increase in 
the synthesis of receptors. Such an ongoing increase in AChR 
levels suggests an accelerating k÷ when assessed as insertion 
rate per dish. The average net AChR accumulation in controls 
dishes for three such experiments was found to be 0.087 ___ 
0.034 fM/h per dish (SEM). Using this value for dA/dt, and 
the  degradation  rate determined  above,  the average AChR 
insertion  rate (k÷)  in control cultures over the 72-h experi- 
mental  period  was  calculated  to  be  0.31  +  0.09  (mean  __. 
SEM; n  =  3) fM/h per dish.  With this calculated insertion 
rate, it is clear that the AChR levels observed experimentally 
at  72  h  after the  first  addition  of ascorbate (i.e.,  a  3.5-fold 
increase) cannot be achieved merely by decreasing the degra- 
dation rate from the 0.050 h -~ to the 0.037 h -~ value obtained 
after ascorbate treatment.  Such a change in degradation rate 
would increase receptor site density only 1.25-fold in 72 h. In 
fact,  if the insertion  rate calculated  for control cultures re- 
mained the same after ascorbate, there is no rate of degrada- 
tion which could produce a  3.5-fold increase in receptors in 
72 h  or less.  Using the above equation and the degradation 
rate measured in ascorbate-treated cells, the average insertion 
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Figure 2.  Effects  of Ara-C on  the  ascorbic acid-induced AChR 
increase. AChR level is plotted as a function of dose of ascorbic acid. 
AChR levels are given for cultures receiving 24-h pre-treatment with 
Ara-C ([7) or no Ara-C (O). Media concentration of Ara-C in treated  5  20(3 
cultures was 10 #M. Percent increase = [(EXP -  CTL)/CTL] x  100, 
where EXP is the mean specific counts bound to cultures receiving a  ~  I O0 
given dose of ascorbic acid and  CTL is the mean specific counts  __~  ( 
bound  to  control cultures not  receiving  ascorbic acid. Individual  o  control values were determined for cultures receiving Ara-C and for 
those that did not. Associated relative errors were calculated as the 
square root of the sums of squares  of the relative error for controls  ~  ~ 
and experimentals.  ~E 
rate (k+) was calculated for the ascorbate-treated cultures. A  ~  I 5 
2.8-fold increase was obtained for the average k÷, from 0.3 l 
_+ 0.09 fM/h per dish in control cells to 0.85 _+ 0.2 fM/h per  5  I0 
dish  in  ascorbate-treated cells.  Since  the  measurements  of  <  5 
creatine kinase (Table I) and nuclei in myotubes (see previous 
section) indicate ascorbic acid does not stimulate myoblast  t~  0 
fusion, the 2.8-fold increase in k÷ applies to the insertion rate 
per unit area of myotube even though the actual k÷ values 
are a composite rate for both the appearance of new myotubes 
and the insertion rate per myotube. 
Acetylcholine Receptor Induction Is a Specific 
Response to Ascorbic Acid 
To  determine whether the stimulation of new  receptors by 
ascorbic acid, described above, was due to an  overall effect 
on protein synthesis, two experimental approaches were used. 
First, the effect of ascorbic acid on cellular total protein levels 
was  determined.  Total  protein  levels in  ascorbic  acid and 
control cultures were followed for a number of days. 3 d after 
the  first  addition  of ascorbic acid and  2  d  after  the  final 
addition, the total protein level was increased to 170 _+ 4 #g/ 
dish (mean _+ SEM; n  =  3), ~25% greater than the  138  _+ 8 
t~g measured in untreated controls (Fig. 3B). This increase in 
total protein is an order of magnitude less than the increase 
in AChR (Fig. 3A). Furthermore, the increase in total protein 
must be due to the mitogenic effect of ascorbic acid described 
above. We determined that there is ~0.5  ng of protein per 
myoblast in  exponentially growing cells. With the total in- 
crease in mononucleated cells on day 7  in ascorbate-treated 
cultures (~7 x  104 cells), an increase in total protein of 36 ug 
was expected. This compares well to the observed total protein 
increase of 32  tzg. Thus  ascorbic acid does not stimulate a 
general  increase  in  total  protein  synthesis in  differentiated 
myotubes. 
A  j 
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Figure 3. Time course of ascorbic acid effects on AChR's (A), total 
protein (B), and creatine kinase (C). The level of each parameter 
measured is presented here as a function of days in culture. In each 
panel the responses to ascorbic  acid are indicated  by (FI)  and untreated 
controls by (O). 15 #g of ascorbic acid were added on days 4 and 5 
(arrows). The data in A is from a single experiment for which most 
data points were available. Average data from three such experiments 
is given in Results.  B and C represent the pooled data from three 
experiments. Error bars in A are SEMs for triplicate determinations. 
Error bars in B and C (determined as for A) are within the size of  the 
symbols and thus not shown. 
The  second test for the specificity of the ascorbate effect 
was the determination of creatine kinase levels, another de- 
velopmentally  regulated protein of  differentiating  muscle (39). 
The development of creatine kinase activity in L5 cells during 
differentiation is shown  in Fig.  3 C.  Between days 3  and  7, 
when the cells are fusing and differentiating into myotubes, 
there is a  14-fold increase in creatine kinase activity from 0.50 
_+  0.01  U/well (mean  _+  SEM;  n  =  3) to  6.80  _+  0.40.  No 
significant difference, however,  was  observed between  cells 
treated with ascorbic acid and the untreated control cells. The 
levels of creatine kinase activity are known to correlate well 
with the extent of muscle differentiation (39).  These results 
not  only confirm  that  ascorbic acid treatment  induces  no 
general increase in total protein synthesis but also that it does 
not stimulate the differentiation of new myotubes. 
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Expression  with Similar Specificity 
Since ascorbic acid was found to be the major component in 
the fraction of brain extract causing receptor induction (23), 
brain extract was compared with ascorbic acid to see if it has 
the  same  specificity with  respect  to  the  other  parameters 
measured. The dam are given in Table I. Among those param- 
eters studied,  only the total protein levels were significantly 
different between cultures treated with ascorbic acid and those 
treated with brain extract. The difference, however, was only 
10%. It is concluded from this comparison that ascorbic acid 
and brain extract have similar specificity in their induction of 
AChR expression in L5 cells. 
Ascorbic Acid Induces AChR Clustering 
Previous studies have shown that brain extracts also induce 
the clustering of AChR on Ls cells. Those clusters produced 
by crude brain extract are induced mainly in response to high 
molecular weight components. Clusters in extract-treated cul- 
tures  occur more frequently and  with  higher  site densities 
than  those  produced  by a  partially purified low  molecular 
weight active component (31).  Therefore, ascorbic acid was 
compared to brain extracts for its effect on receptor clustering. 
Overexposed autoradiograms were prepared for both ascorbic 
acid and newborn rat brain extract-treated cultures (see Ma- 
terials and Methods). Dishes were scanned and clusters iden- 
tiffed subjectively (see Fig. 4). The frequency of occurrence of 
clusters was determined for cells treated with either ascorbic 
acid or brain extract, as well as for untreated control cells. 
Extract-treated cultures had -25 times more clusters per unit 
area of myotube than control cultures, and 4.5  times more 
clusters than cultures receiving ascorbic acid (Table II). The 
effect of ascorbate was thus similar to that of the low molec- 
ular weight component of brain extract (31). 
Duplicate autoradiograms were also prepared with shorter 
exposure times intended to be appropriate for grain counting. 
Clusters were often found to have high density cores (defined 
as at least 39  #m  2 with average site densities >2,000  sites/ 
~m  2) which tended to locally overexpose the emulsion. Clus- 
ters with such  high density cores, which we will  call  "high 
density  clusters,"  were  easily  identified  subjectively.  High 
density  clusters  were  not  seen  in  untreated  controls  and 
represented 20-30% of the total number of clusters in dishes 
receiving ascorbic acid or brain extract (Table II). Again, there 
were -5  times more high density clusters per unit  area on 
brain extract than on ascorbic acid-treated cells. To estimate 
Figure 4. Overexposed scanning electron microscope autoradiogram of AChR clusters on extract-treated (left) and ascorbic acid-treated (right) 
L5 cell.  Arrowheads help delineate cell margins and arrows point to receptor clusters illustrating variation in cluster shape. Both types of clusters 
were seen on either treatment. Bar,  10 #m. 
Table II. Induction of  AChR Clusters 
Fetal rat brain ex- 
Control  tract  Ascorbic acid 
Number of clusters (per  l0  s t*m  2 of myotube)*  2.87 ±  1.7  71 -+ 17  15.8 ± 6 
% of total clusters that are high density clusters*  0  22_2 +__ 8  273 ± 6.5 
Average size (~m  z) of high density clusters  °t  0  148_6 -.+ [  6  (31 )  88.5 ± 21  ( 1  I 
% (× 102) of myotube surface area that is >2,000 sites/~m ~  0  18_0 -+ 0.2  2.1 ± 0.2 
* Determined from overexposed autoradiograms  (see Materials and Methods for details). 
*  A high density cluster is defined as one with a minimum core area of 39 gm  2 containing  an AChR site density ~2,000  sites/urn 2. The number of high densily 
clusters per ~m  2 of myotube determined  from low exposure autoradiograms  (0.035-0.5  grains/um  2) was divided by the number of clusters per um  2 of myolube 
determined  from overexposed autoradiograms. 
Determined  from autoradiograms  exposed for grain counting (see Materials and Methods). These numbers represent the average area of the high density clusters. 
See Materials and Methods  for determination  of total cluster boundaries  by the "3 times"  criteria. We assayed 2.38-2.57  x  0.06 #m  2 of myotube  per dish per 
experiment (520-552  counting fields). Numbers in parentheses indicate the total number of high density clusters examined. 
m  In addition to a larger overall size of the high density clusters in extract-treated cells, the size of the high density core increased as well, making the % area of the 
high density clusters occupied by the high density core roughly the same (60-70%) in both extract- and aseorbate4reated  cultures. 
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defined  quantitatively  relative  to  average  site  density  (see 
Materials and Methods). Table II shows that the high density 
clusters  on brain extract-treated cells were ~60% larger than 
those formed on ascorbate acid-treated ones.  The high site 
density cores of these clusters were also -60% larger on brain 
extract-treated cells than on ascorbic acid-treated cells. This 
increase in core size, in addition to the larger number of high 
density clusters,  resulted  in an overall  8.5-fold  larger surface 
area of myotubes occupied by the high density core regions 
in  the  extract-treated  cultures  than  in  those  treated  with 
ascorbic acid. 
Discussion 
Ascorbic acid was demonstrated previously to be the primary 
active component in fetal calf brain extract causing increased 
AChR levels on L5 cells in vitro (23). This effect was shown 
to be specific for ascorbic acid and not to be a general property 
of reducing agents.  In the present work the action of ascorbic 
acid has been studied in greater detail. It was shown that while 
ascorbic acid can act as a  mitogen, the mitogenic effect can 
be blocked without altering the increase in AChR's. In addi- 
tion, total protein and creatine kinase levels, whose half-lives 
are  roughly equal  to that  of AChR's (16,  42,  43),  are  not 
increased by ascorbic acid to the extent  that the AChR is. 
Taken together, these  results  indicate that general effects of 
ascorbic  acid  on  protein  synthesis,  cell  growth,  or  fusion 
cannot account for the more than threefold increase  seen in 
the receptor number. It was also shown that the ascorbic acid- 
induced elevation of surface  AChR site  density on L5 cells 
must  be  due  primarily  to  an  accelerated  rate  of receptor 
insertion (2.8-fold)  into the surface  membrane since  only a 
slight decrease  in degradation rate of receptors is seen.  This 
conclusion is  similar  to  that  previously reached  for brain 
extracts on L5 cells (31) and chick primary muscle cells (17). 
Preliminary results from our laboratory (22) show an increase 
in mRNA levels for the alpha subunit of AChR in L5 cells 
treated with ascorbate; thus it is likely that elevated  levels of 
receptor synthesis account for the increased receptor insertion. 
A  number  of different  studies  have  reported  that,  like 
AChR's, the ascorbic acid levels of skeletal  muscle undergo 
changes both as a consequence of normal cellular differentia- 
tion, and after denervation. For example, in both chick and 
rat  muscle,  ascorbic  acid  levels  are  high  before birth  and 
undergo perinatal declines (1 l, 20, 33), and in several animals 
ascorbic acid levels have been shown to increase  after dener- 
vation (14,  24). Levels of AChR in skeletal  muscle are also 
higher in embryonic and denervated muscle than in postnatal 
and innervated muscle (1,  3,  6,  30). Furthermore, we have 
found (data not shown) that the ascorbic acid-induced AChR 
increase  in L~ cells is accompanied by an elevation in intra- 
cellular ascorbic acid levels from a value of <0.03 ug/ml total 
protein to greater than  1.5 ~g/mg, a value similar to embry- 
onic  skeletal  muscle  levels  (11,  20,  33). This  information 
suggests a  direct relationship between intracellular levels of 
ascorbic acid and AChR synthesis. 
Ascorbic acid also causes the formation of AChR clusters 
on L5 cells. We found (data not shown) that, as in the case of 
clusters  formed by brain extract (36), ascorbic acid-induced 
clusters  are formed by a redistribution of pre-existing  recep- 
tors.  However,  unlike  the  effect  on  receptor  site  density, 
ascorbic acid is much less effective than crude brain extract 
in causing receptor duster formation. The observations made 
in the present work are compatible with previous observations 
(31)  that  a  low  molecular weight  fraction  of crude  brain 
extract,  which causes the major increase  in surface  receptors 
on  Ls  cells,  is  not  the  major  cluster-inducing  substance. 
Cluster-inducing  activity in  crude  extract  has  a  range  of 
apparent molecular weights but predominates in high molec- 
ular weight fractions. 
Neugebauer et al. (3 l) found that unlike L5 cells, rat primary 
muscle cells are insensitive  to the low molecular weight frac- 
tion. Consistent with this, we found that rat primary cells also 
show  no  increase  in  receptor  site  density  after  ascorbate 
(Knaack, D.,  I. Shen,  M.  M.  Salpeter,  and T.  R.  Podleski, 
unpublished observations).  However, Kalcheim et al. (18, 19) 
found that ascorbate causes  receptor clusters  in rat primary 
cells, which is not compatible with the results predicted from 
the work by Neugebauer et al. (31). We have not yet examined 
the cluster response of primary rat cells to ascorbic acid under 
our culturing conditions. 
There are several possible  sources of ascorbic acid in vivo 
which could influence muscle.  Blood plasma is one, and the 
levels of ascorbic acid that we have used are in the range of 
those found in serum (15). The nervous system may also be 
a  primary source of ascorbate.  Brain levels of ascorbic acid 
are among the highest  in the body (15). Furthermore, neu- 
ronal release of ascorbic acid has been demonstrated in brain 
preparations (4), and it has been reported that ciliary ganglia 
release  an  ascorbic  acid-like  substance  (40).  Since  ciliary 
ganglia contain predominantly cholinergic  motor neurons, it 
is possible  that  motor neurons could serve  as  a  source of 
ascorbic acid for skeletal muscle. How ascorbic acid in serum 
and neural tissue could interact to produce the changes asso- 
ciated with innervation and denervation is not known. 
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